Electrophysiological Signatures of Cognitive Disorders Related to Intensive Care Unit (ICU) delirium_ BRAINSTORM-EEG (B-EEG)

Toulouse University Hospital

Status: Not yet enrolling

Conditions: Cognitive Dysfunction

Treatments: Diagnostic Test: mEEG battery

Study type: Interventional

Funder types: Other

Identifiers

NCT06089538

RC31/22/0526

2023-A00935-40 (Other Identifier)

Details and patient eligibility

About

Early cognitive assessment of critically-ill acute respiratory distress syndrome (ARDS) patients with delirium using a multidimensional electrophysiological evaluation battery (mEEG) to identify and characterize the neural correlates of cognitive dysfunctions associated with delirium (vigilance, attention, semantic and lexical processing, self-processing), and to develop a prognostic evaluation of neurocognitive and psychological disorders using an innovative non-behavioral approach.

Full description

Delirium is an altered mental status associated with specific manifestations such as reduced ability to direct, focus, maintain and shift attention Diagnostic Medical Systems V criteria (DSM). The vulnerability of critically-ill acute respiratory distress syndrome (ARDS) patients explains the high incidence of delirium (up to 80%) in this setting. Delirium is an independent predictor of post-traumatic stress disorder, long term cognitive decline and mortality. To reduce this medical and social burden, a more complete description of delirium is needed both in terms of cognitive impairments and long term neurological and neuropsychological impact. Actually, it could be argued that the current exclusive behavioral assessment of these patients is insufficient in terms of diagnosis and prognostic assessment. In recent years, the study of consciousness has made major progress thanks to the use of innovative electrophysiological exploration methods. This work has notably allowed the development of new non-behavioral tools for the exploration of brain function in brain damaged patients in response to complex auditory stimulations (multidimensional electrophysiological battery, mEEG). In this context, the investigators have recently demonstrated alterations in cognitive functions related to language- and self-processing in acute respiratory distress syndrome (ARDS) patients with severe acute respiratory syndrome (SARS) - COVID-19 infection. These electrophysiological cognitive alterations were particularly marked in COVID-19 patients with delirium. Further studies are needed to disentangle the cognitive impact specifically related to delirium from that related to a severe form of COVID-19. The primary objective of this study is to identify diagnostic electrophysiological signatures of cognitive dysfunctions associated with the acute phase of delirium in critically-ill acute respiratory distress syndrome (ARDS) patients using a multidimensional electrophysiological assessment (mEEG) recording at rest and during auditory stimulation (first visit). Secondary objectives are to characterize the impact of intensive care unit (ICU)-related delirium on neurocognitive and psychological dysfunctions observed at 6 months (second visit), in order to explore the prognostic predictive value of electrophysiological data acquired during the acute phase of delirium.

Enrollment: 60 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients admitted to the intensive care unit with ARDS (according to Berlin criteria)
• Membership of a social security scheme
• Signed consent of the patient (group without delirium) or referring person (group with delirium)
• Discontinuation of any sedative agent for ≥ 72 hours

Exclusion criteria

• Pre-existing psychotic disorders
• Pre-existing cognitive deficits
• Patients with chronic ethylism
• Previous neurological history
• Recent ICU admission (> 5 days of ICU hospitalization within 6 months prior to current ICU admission)
• Patients whose delirium cannot be reliably assessed due to blindness, deafness or inability to speak French
• Patients whose life expectancy is unlikely to exceed 24 hours
• Pregnant women
• Patients under court protection
• Patients who have already participated in the study

Trial design

Primary purpose: Other

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

60 participants in 2 patient groups

Delirium patients group

Experimental group

Description:

Patients admitted for acute respiratory distress syndrome (ARDS) who developed delirium

Treatment:

Diagnostic Test: mEEG battery

Patients without delirium

Active Comparator group

Description:

Patients admitted for acute respiratory distress syndrome (ARDS) who did not developed delirium

Treatment:

Diagnostic Test: mEEG battery